Lyme disease might be the poster child of tick-borne illnesses, but experts say another is on an absolute meteoric rise this year. It’s called babesiosis and the US could be in for exponentially higher cases of the disease this year. Veuer’s Tony Spitz has the details.
A new voluntary registry system is being developed for patients diagnosed with sickle cell disease in South Carolina.
State lawmakers directed the S.C. Department of Health and Environmental Control to create and maintain a sickle cell disease voluntary patient registry in 2022.
DHEC selected Global Vision Technologies’ ClinicalPURSUIT, which will launch later this year.
The information entered into the voluntary registry will help organizations make treatment decisions for patients in South Carolina.
It will also allow DHEC or clinicians to enter patient data; review, analyze and act on results quickly and benchmark outcomes.
It also offers the opportunity for clinical scientific research using the registry findings. Data used for clinical research will not identify patients participating in the voluntary registry.
People are also reading…
The system will also include a patient portal for patients to document their experiences, update their information and share their medical information with their providers.
#lee-rev-content { margin:0 -5px; } #lee-rev-content h3 { font-family: inherit!important; font-weight: 700!important; border-left: 8px solid var(–lee-blox-link-color); text-indent: 7px; font-size: 24px!important; line-height: 24px; } #lee-rev-content .rc-provider { font-family: inherit!important; } #lee-rev-content h4 { line-height: 24px!important; font-family: “serif-ds”,Times,”Times New Roman”,serif!important; margin-top: 10px!important; } @media (max-width: 991px) { #lee-rev-content h3 { font-size: 18px!important; line-height: 18px; } } #pu-email-form-daily-email-article { clear: both; background-color: #fff; color: #222; background-position: bottom; background-repeat: no-repeat; padding: 15px 0 20px; margin-bottom: 40px; border-top: 4px solid rgba(0,0,0,.8); border-bottom: 1px solid rgba(0,0,0,.2); display: none; } #pu-email-form-daily-email-article, #pu-email-form-daily-email-article p { font-family: -apple-system, BlinkMacSystemFont, “Segoe UI”, Helvetica, Arial, sans-serif, “Apple Color Emoji”, “Segoe UI Emoji”, “Segoe UI Symbol”; } #pu-email-form-daily-email-article h2 { font-size: 24px; margin: 15px 0 5px 0; font-family: “serif-ds”, Times, “Times New Roman”, serif; } #pu-email-form-daily-email-article .lead { margin-bottom: 5px; } #pu-email-form-daily-email-article .email-desc { font-size: 16px; line-height: 20px; margin-bottom: 5px; opacity: 0.7; } #pu-email-form-daily-email-article form { padding: 10px 30px 5px 30px; } #pu-email-form-daily-email-article .disclaimer { opacity: 0.5; margin-bottom: 0; line-height: 100%; } #pu-email-form-daily-email-article .disclaimer a { color: #222; text-decoration: underline; } #pu-email-form-daily-email-article .email-hammer { border-bottom: 3px solid #222; opacity: .5; display: inline-block; padding: 0 10px 5px 10px; margin-bottom: -5px; font-size: 16px; } @media (max-width: 991px) { #pu-email-form-daily-email-article form { padding: 10px 0 5px 0; } } .grecaptcha-badge { visibility: hidden; }
